Proportion of patients who experience a clinical ischemic stroke
The proportion of patients who experience a clinical ischemic stroke within 3 days will be compared between the two groups (i.e., standard cannula versus the CardioGard device).
Proportion of patients who experience a clinical ischemic stroke
The proportion of patients who experience a clinical ischemic stroke within 7 days will be compared between the two groups (i.e., standard cannula versus the CardioGard device).
Number of patients with disabling clinical stroke
Number of patients with disabling clinical stroke within 3 days post-randomization
Number of patients with disabling clinical stroke
Number of patients with disabling clinical stroke within 7 days post-randomization
Neurological outcomes assessed by National Institutes of Health Stroke Scale (NIHSS)
Neurological outcomes are assessed by National Institutes of Health stroke Scale (NIHSS) to compare the treatment outcomes of three types of service delivery models. The NIHSS is an 11-item impairment scale to evaluate neurologic outcome and degree of recovery.
Each item is scored between 0 and up to 4, total score ranges 0 (normal function) and a maximum possible score 42, with higher score indicating higher level of impairment.
These assessments will be administered by blinded neurology trainees or study coordinators who are certified to administer the assessments.
Neurological outcomes assessed by National Institutes of Health Stroke Scale (NIHSS)
Neurological outcomes are assessed by National Institutes of Health stroke Scale (NIHSS) to compare the treatment outcomes of three types of service delivery models. The NIHSS is an 11-item impairment scale to evaluate neurologic outcome and degree of recovery.
Each item is scored between 0 and up to 4, total score ranges 0 (normal function) and a maximum possible score 42, with higher score indicating higher level of impairment.
These assessments will be administered by blinded neurology trainees or study coordinators who are certified to administer the assessments.
Number of patients with disabling clinical stroke determined by modified Rankin Scale (mRS) score ≥2
Number of patients with disabling clinical stroke as indicated by mRS score ≥2. mRS will be assessed at baseline days.
The scale runs from 0-6, running from perfect health without symptoms to death. A higher score indicates greater impairment.
0 - No symptoms.
- No significant disability. Able to carry out all usual activities, despite some symptoms.
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
3. - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to walk and attend own bodily needs without assistance.
5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
6 - Dead.
Number of patients with disabling clinical stroke determined by modified Rankin Scale (mRS) score ≥2
Number of patients with disabling clinical stroke as indicated by mRS score ≥2. mRS will be assessed at 30 days.
The scale runs from 0-6, running from perfect health without symptoms to death. A higher score indicates greater impairment.
0 - No symptoms.
- No significant disability. Able to carry out all usual activities, despite some symptoms.
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
3. - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to walk and attend own bodily needs without assistance.
5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
6 - Dead.
Number of patients with disabling clinical stroke determined by modified Rankin Scale (mRS) score ≥2
Number of patients with disabling clinical stroke as indicated by mRS score ≥2. mRS will be assessed at 90 days.
The scale runs from 0-6, running from perfect health without symptoms to death. A higher score indicates greater impairment.
0 - No symptoms.
- No significant disability. Able to carry out all usual activities, despite some symptoms.
- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities.
3. - Moderate disability. Requires some help, but able to walk unassisted. 4 - Moderately severe disability. Unable to walk and attend own bodily needs without assistance.
5 - Severe disability. Requires constant nursing care and attention, bedridden, incontinent.
6 - Dead.
Montreal Cognitive Assessment (MoCA) Score
Global cognitive screening performance will be compared between groups and collected via the Montreal Cognitive Assessment (MoCA) - blind version at presurgical baseline.
The MoCA scale is used for detecting cognitive impairment. The scores range between 0 to 30 points; a score of 26 or above was considered normal. Higher values represent a better outcome.
Montreal Cognitive Assessment (MoCA) Score
Global cognitive screening performance will be compared between groups and collected via the Montreal Cognitive Assessment (MoCA) - blind version at 90 days.
The MoCA scale is used for detecting cognitive impairment. The scores range between 0 to 30 points; a score of 26 or above is considered normal. Higher values represent a better outcome.
Montreal Cognitive Assessment (MoCA) Score
Global cognitive screening performance will be compared between groups and collected via the Montreal Cognitive Assessment (MoCA) - blind version at 12 months.
The MoCA scale is used for detecting cognitive impairment. The scores range between 0 to 30 points; a score of 26 or above is considered normal. Higher values represent a better outcome.
Hopkins Verbal Learning Test-Revised (HVLT-R) (verbal learning and memory) Score
HVLT-R is a structured word-list memory test that contains 12 nouns that are read to a participant for three consecutive trials. After each trial, a participant is asked to recall the words that were read to them. The number of words recalled on each trial is summed together to produce a total score for immediate recall and learning. Participants are also asked to recall learned word-list items after a 20-minute delay, yielding a delayed recall score. Participants also perform a subsequent recognition task where they affirm or deny recognition of the word-list materials (from a larger group of 12 target and 12 foil words), the results of which provide a score for recognition discriminability (i.e., target hits - foil misses). The scores for all of these HVLT-R variables are converted to standardized "T" scores using normative data. The possible "T" score for each participant ranges from 20 to 80, with higher scores indicative of a better outcome
Hopkins Verbal Learning Test-Revised (verbal learning and memory) Score
Hopkins Verbal Learning Test-Revised (HVLT-R) is a structured word-list memory test that contains 12 nouns that are read to a participant for three consecutive trials. After each trial, a participant is asked to recall the words that were read to them. The number of words recalled on each trial is summed together to produce a total score for immediate recall and learning. Participants are also asked to recall learned word-list items after a 20-minute delay, yielding a delayed recall score. Participants also perform a subsequent recognition task where they affirm or deny recognition of the word-list materials (from a larger group of 12 target and 12 foil words), the results of which provide a score for recognition discriminability (i.e., target hits - foil misses). The scores for all of these HVLT-R variables are converted to standardized "T" scores using normative data. The possible "T" score for each participant ranges from 20 to 80, with higher scores indicative of a better outcome.
Hopkins Verbal Learning Test-Revised (verbal learning and memory) Score
Hopkins Verbal Learning Test-Revised (HVLT-R) is a structured word-list memory test that contains 12 nouns that are read to a participant for three consecutive trials. After each trial, a participant is asked to recall the words that were read to them. The number of words recalled on each trial is summed together to produce a total score for immediate recall and learning. Participants are also asked to recall learned word-list items after a 20-minute delay, yielding a delayed recall score. Participants also perform a subsequent recognition task where they affirm or deny recognition of the word-list materials (from a larger group of 12 target and 12 foil words), the results of which provide a score for recognition discriminability (i.e., target hits - foil misses). The scores for all of these HVLT-R variables are converted to standardized "T" scores using normative data. The possible "T" score for each participant ranges from 20 to 80, with higher scores indicative of a better outcome.
Brief Visuospatial Memory Test - Revised (visual learning & memory and constructional praxis)
Analogous to the HVLT-R, the Brief Visuospatial Memory Test (BVMT-R) assesses visual learning and memory by measuring how well individuals can recall a page of six line drawings presented visually for 10 seconds over three repetition trials. Examinee totals from the three repetition trials is taken as a measure of visual short-term learning and memory, and after a 20-minute delay, examinees are asked to reproduce as many as possible of the previously presented line drawings (assessing long-term visual memory retention and recall). Examinees are then shown 12 line drawings, six of which were the line drawings they were asked to reproduce earlier and six new drawings, and examinees are asked if they recognize the line drawings as ones they have seen before (assessing long-term visual recognition memory). Raw scores are converted to T-scores, normed by age and sex. A higher T-score representing a better outcome.
Oral Trail Making Test - Parts A and B (executive function)
The Trail Making Test consists of 25 circles distributed over a sheet of paper. In Part A, the circles are numbered 1 - 25, and the patient should draw lines to connect the numbers in ascending order. In Part B, the circles include both numbers (1 - 13) and letters (A - L); as in Part A, the patient draws lines to connect the circles in an ascending pattern, but with the added task of alternating between the numbers and letters (i.e., 1-A-2-B-3-C, etc.). The patient should be instructed to connect the circles as quickly as possible, without lifting the pen or pencil from the paper. Time the patient connects the "trail." If the patient makes an error, point it out immediately and allow the patient to correct it. Results for part B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.
Oral Trail Making Test - Parts A and B (executive function)
The Trail Making Test consists of 25 circles distributed over a sheet of paper. In Part A, the circles are numbered 1 - 25, and the patient should draw lines to connect the numbers in ascending order. In Part B, the circles include both numbers (1 - 13) and letters (A - L); as in Part A, the patient draws lines to connect the circles in an ascending pattern, but with the added task of alternating between the numbers and letters (i.e., 1-A-2-B-3-C, etc.). The patient should be instructed to connect the circles as quickly as possible, without lifting the pen or pencil from the paper. Time the patient connects the "trail." If the patient makes an error, point it out immediately and allow the patient to correct it. Results for part B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.
Oral Trail Making Test - Parts A and B (executive function)
The trail Making Test consist of 25 circles distributed over a sheet of paper. In Part A, the circles are numbered 1 - 25, and the patient should draw lines to connect the numbers in ascending order. In Part B, the circles include both numbers (1 - 13) and letters (A - L); as in Part A, the patient draws lines to connect the circles in an ascending pattern, but with the added task of alternating between the numbers and letters (i.e., 1-A-2-B-3-C, etc.). The patient should be instructed to connect the circles as quickly as possible, without lifting the pen or pencil from the paper. Time the patient connects the "trail." If the patient makes an error, point it out immediately and allow the patient to correct it. Results for part B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.
Wechsler Adult Intelligence Scale-Revised (WAIS-R) Digit Span (auditory-verbal attention)
The WAIS-R Digit Span test assesses short term or working memory. The examinee listens to sequences of numbers orally and then repeats them as heard, in increasing order, and in reverse order. The raw scores for "digit span" range from a minimum of 2 to a maximum of 8. For this test, the longer the span the better the cognition; therefore, the higher score is the better outcome.
Wechsler Adult Intelligence Scale-Revised (WAIS-R) Digit Span (auditory-verbal attention)
The WAIS-R Digit Span test assesses short term or working memory. The examinee listens to sequences of numbers orally and then repeats them as heard, in increasing order, and in reverse order. The raw scores for "digit span" range from a minimum of 2 to a maximum of 8. For this test, the longer the span the better the cognition; therefore, the higher score is the better outcome.
Wechsler Adult Intelligence Scale-Revised (WAIS-R) Digit Span (auditory-verbal attention)
The WAIS-R Digit Span test assesses short term or working memory. The examinee listens to sequences of numbers orally and then repeats them as heard, in increasing order, and in reverse order. The raw scores for "digit span" range from a minimum of 2 to a maximum of 8. For this test, the longer the span the better the cognition; therefore, the higher score is the better outcome.
Wechsler Adult Intelligence Scale-Revised (WAIS-R) Digit Symbol Substitution Test (processing speed)
The WAIS-R Digit Symbol Substitution Test (DSST) is a paper-and-pencil cognitive test that consist of number-symbol pairs. It requires the examinee to copy, into spaces below rows of numbers, the symbols that are paired to each number. The DSST score is the number of digits coded correctly in a 90-second test period
Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test (verbal fluency/executive function)
The D-KEFS Verbal Fluency Test is comprised of three testing conditions: Letter Fluency, Category Fluency, and Category Switching. This test measures multiple aspects of verbal productivity and cognitive flexibility. It evaluates effectiveness of novel and semantic search strategies, and assesses flexibility in the implementation of word search strategies. There are three conditions in the test in which the examinee must say as many words as they can by letter, category, and category switching prompts.
Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test (verbal fluency/executive function)
The D-KEFS Verbal Fluency Test is comprised of three testing conditions: Letter Fluency, Category Fluency, and Category Switching. This test measures multiple aspects of verbal productivity and cognitive flexibility. It evaluates effectiveness of novel and semantic search strategies, and assesses flexibility in the implementation of word search strategies. There are three conditions in the test in which the examinee must say as many words as they can by letter, category, and category switching prompts.
Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency Test (verbal fluency/executive function)
The D-KEFS Verbal Fluency Test is comprised of three testing conditions: Letter Fluency, Category Fluency, and Category Switching. This test measures multiple aspects of verbal productivity and cognitive flexibility. It evaluates effectiveness of novel and semantic search strategies, and assesses flexibility in the implementation of word search strategies. There are three conditions in the test in which the examinee must say as many words as they can by letter, category, and category switching prompts.
Incidence of Delirium
The incidence of delirium will be assessed daily by the Confusion Assessment Method (3D-CAM or CAM-ICU for intubated patients) during the first 7 days post-randomization.
The CAM consists of 4 features: 1-Onset, 2-Inattention, 3-Disorganized thinking, and 4-altered level of consciousness. The diagnosis of delirium by CAM is based on the presence of features 1 and 2, and either 3 or 4 and involves the presence/absence of delirium, but not its severity. Any error or behavioral observation consistent with a delirium feature means that feature is present.
Duration of Delirium
The duration of delirium will be measured as the number of days with positive CAM assessments by 7 days post-randomization.
The CAM consists of 4 features: 1-Onset, 2-Inattention, 3-Disorganized thinking, and 4-altered level of consciousness. The diagnosis of delirium by CAM is based on the presence of features 1 and 2, and either 3 or 4.
Severity of Delirium
The severity of delirium will be measured during daily screening using standardized algorithms for extracting symptom severity from the 3D-CAM and CAM-ICU.
Number of Patients who experience Acute kidney injury (AKI)
Number of Patients who experience Acute kidney injury will be assessed within 7 days post-randomization.
All-cause mortality
All-cause mortality within 90 days post-randomization will be assessed.
All-cause mortality
All-cause mortality within 12-months post-randomization will be assessed.
Length of Index Hospitalization
Overall length of stay for the index hospitalization post-randomization will be measured and broken down by days spent in the ICU versus days not in the ICU.
Discharge disposition
Discharge disposition
Readmissions rates
Readmission rates will be calculated for the first 90 days following randomization. Hospitalizations will be classified for all causes including for cardiovascular readmissions.
Readmissions rates
Readmission rates will be calculated for the duration of follow-up, out to 1 year. Hospitalizations will be classified for all causes including for cardiovascular readmissions.
Days Alive out of Hospital
Days alive out of hospital and nursing/rehab facilities within 90 days after randomization